// App-Quantinova.ai

11543 : Assessing tumor heterogeneity using circulating tumor DNA to predict and monitor therapeutic response in metastatic breast cancer.

Researchers

Presenter

  • Fei Ma

Principal Investigators

  • Yanfang Guan

  • Zongbi Yi

  • Lianpeng Chang

  • Xuefeng Xia

  • Qiao Li

  • Shanshan Chen

  • Xin Yi

  • Ling Yang

  • Binghe Xu

Medical Centers

  • Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

  • Geneplus-Beijing, Beijing, China

  • Cancer Institute/Hospital Chinese Academy of Medical Sciences(CAMS) & Peking Union Medical College(PUMC), Beijing, China

  • The Methodist Hospital Research Institute, Houston, TX

  • Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

  • Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • Human epidermal growth factor receptor 2

  • Circulating DNA

Drug/Treatment

  • pyrotinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved